With more than 20 drugs currently licensed to treat HIV infection 1 and over 200 mutations associated with drug resistance 2,3,4,5, it is increasingly difficult to develop a comprehensive ...
Amid the unprecedented challenges presented by the COVID-19 pandemic, a once obscure enzyme found itself in the spotlight: reverse transcriptase. As laboratories worldwide rushed to develop reliable ...